Resonance Health Ltd has today signed a Patient Access to FerriSmart® Letter of Agreement with the World Health Organization related Cyprus based Thalassaemia International Federation (TIF).
Under the agreement, TIF will deploy 500 FerriSmart® vouchers, provided by Resonance Health at no cost, across targeted low-and-middle income countries in Asia, West Pacific, and Europe. Resonance Health will sponsor a dedicated TIF executive. The data collected from the FerriSmart® analysis will be used in TIF’s Global Thalassaemia Review and by Resonance Health to improve and refine its product offerings.
To read the full article please click here.